Yunnan Botanee Bio-Technology GroupLTD Balance Sheet Health
Financial Health criteria checks 5/6
Yunnan Botanee Bio-Technology GroupLTD has a total shareholder equity of CN¥6.1B and total debt of CN¥170.1M, which brings its debt-to-equity ratio to 2.8%. Its total assets and total liabilities are CN¥7.1B and CN¥951.2M respectively. Yunnan Botanee Bio-Technology GroupLTD's EBIT is CN¥701.0M making its interest coverage ratio -7.7. It has cash and short-term investments of CN¥3.0B.
Key information
2.8%
Debt to equity ratio
CN¥170.08m
Debt
Interest coverage ratio | -7.7x |
Cash | CN¥2.95b |
Equity | CN¥6.11b |
Total liabilities | CN¥951.22m |
Total assets | CN¥7.06b |
Recent financial health updates
Recent updates
Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year
Jun 03A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)
May 24Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 02Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet
Feb 29Financial Position Analysis
Short Term Liabilities: 300957's short term assets (CN¥5.0B) exceed its short term liabilities (CN¥743.6M).
Long Term Liabilities: 300957's short term assets (CN¥5.0B) exceed its long term liabilities (CN¥207.6M).
Debt to Equity History and Analysis
Debt Level: 300957 has more cash than its total debt.
Reducing Debt: 300957's debt to equity ratio has increased from 0.7% to 2.8% over the past 5 years.
Debt Coverage: 300957's debt is well covered by operating cash flow (381.9%).
Interest Coverage: 300957 earns more interest than it pays, so coverage of interest payments is not a concern.